ABSTRACT. An association between zinc depletion and intrauterine growth retardation might occur through disturbed prostaglandin (PG) synthesis. The zinc content and PG metabolism of leucocytes from control, nonpregnant women and mothers 24-48 h after delivery, were measured and related to fetal growth and maternal smoking. Mothers of small for gestational age babies had lower polymorphonuclear and mononuclear cell zinc contents than mothers of appropriate for gestational age babies or nonpregnant controls. Monocytes were the major leucocytes producing PGs. Mothers of small for gestational age babies had higher PGE2:Fk ratios than mothers of appropriate for gestational age babies. PGFk production and PGE2:Fk ratio were correlated with tissue zinc status. Monocytes from nonsmokers tended to produce more PGs than those from smokers but the differences were not significant. Mild maternal zinc depletion is not significantly sufficient to alter absolute PC production, but is associated with altered differential production of PGs in human leucocytes. Zinc depletion or malnutrition may contribute to intrauterine growth retardation by affecting placental and/or umbilical PG production. (Pediatr Res 19: 697-700,1985) Abbreviations PC, prostaglandin SGA, small for gestational age AGA, appropriate for gestational age IUGR, intrauterine growth retardation PMN, polymorphonuclear MN, mononuclear MC, monocyte IUGR is an important cause of perinatal morbidity and mortality in developed, as well as developing, countries, and in both animals ( l,2) and man (3,4) occurs with maternal zinc depletion. Zinc is present in many metalloenzymes and is essential for DNA and RNA synthesis and, therefore, protein accumulation and growth (5). It is also important in the structure and function of biomembranes (6). An interaction between zinc and essential fatty acids has been postulated (7, 8) , but aberrations in the metabolism of essential fatty acids attributed to zinc deficiency may be due to the accompanying reduced food intake (9). Zinc may be necessary for at least two stages in essential fatty acid Received December 4, 1984; accepted March 5, 1985. Correspondence to Dr. Karen Simmer, Gastrointestinal Laboratory, Rayne Institute, St. Thomas' Hospital, London SE1 7EH, London.
metabolism, namely the conversion of linoleic acid to y-linolenic acid, and the mobilization of dihommogammalinolenic acid for the synthesis of 1 series PGs. Zinc may also be important in the conversion of dihommogammalinolenic acid to arachidonic acid and for mobilization of arachidonic acid for 2 series PG formation (10) . One of the immediate consequences of zinc depletion may be altered PG metabolism and, as PGs are important in placental function and fetal growth (1 1) , an association between zinc depletion and IUGR might occur through disturbed PG synthesis.
Leucocytes are readily available and produce prostaglandins (12) . Their zinc content is a good indicator of zinc status (13) and they extensively penetrate the placenta (14) . We have investigated the relationship between PG production and zinc depletion in human pregnancy by studying the zinc content and PG metabolism of leucocytes, and relating these to fetal growth and maternal smoking.
PATIENTS AND METHODS
Seventeen mothers were studied 24-48 h after delivery and values compared to those in 17 control, nonpregnant women. The mothers were divided into two groups: group I (n = 11) delivered babies of normal birth weight or AGA, and group I1 (n = 6) delivered SGA babies. Babies were defined as SGA if their birth weight was less than the 10th percentile, corrected for gestational age, sex, race, and maternal height. Group I had a mean age of 27 yr (range 17-34 yr), group I1 23 yr (range 19-36 yr), and the control group, 27 yr (range 22-29 yr). Mothers of small but AGA, namely preterm, babies were not studied.
Preparation of PMN and MC cell populations. Peripheral venous blood was collected at 0900 h into heparin, 10 U/ml (Leo Laboratories Ltd, Bucks, England). Thirty six milliliters blood with 9 ml dextran 150 in 0.16 M NaCl (Fisons, Loughborough, England) was sedimented for 20-30 min (15) and the supernatant layered on Ficoll-Paque (Pharmacia Fine Chemicals, Uppsala, Sweden) and centrifuged at room temperature for 20 min at 400 X g (16) . PMN and MN cells were separated, and contaminating red blood cells were removed by hypotonic lysis. The cells were resuspended in phosphate buffer solution.
Cell counts and assessment of population purity were performed manually, using a Neubauer haemocytometer chamber after methylene blue staining. Purities were greater than 90% for PMN cells and 80% for MN cells. The percentage composition of the MN population was assessed by staining for nonspecific esterases (1 7, 18) . Viability was established by vital dye exclusion, using 15% trypan blue in 0.15 M saline (19) , and was always , greater than 95 %.
To determine which subpopulation of MN cells was producing the majority of PGs, the MN cell suspensions from three additional mothers were depleted of MCs by glass adherence. The concentration of lymphocytes was maintained and incubations were performed in parallel with the original MN cells.
Cell incubations. Cell incubations were performed in duplicate at 37" C in 2 ml TC 199 medium (Wellcome Reagents, Beckenham, England) and 20 mM HEPES buffer (Flow Laboratories, Rickmansworth, England), pH 7.4. Cells were incubated at a density of lo5 monocytes per milliliter and stimulated with zymosan, 50 pg/ml medium (Sigma Chemical Co., Dorset, England). PMN cells were also stimulated with N-formyl-L-methionyl-L-leucyl-phenylalanine, 2.5 X lo-' M (Sigma).
Incubations were stopped by centrifugation and the supernatants stored at -70" for less than 4 wk before analysis.
Zinc analysis. After cells had been removed for incubation, the remainder were digested for 3 days in 5-10 ml 0.1 M nitric acid and the zinc content was measured by flame atomic absorption spectrophotometry (Instrumentation Laboratory 257 Cheshire, England). Precision of the assay, assessed as within-assay and between-assay coefficient of variation, was always less than 3%.
Both internal and external zinc standards (Nyegaard, Birmingham, England) were used with 98% agreement.
PG analysis. Analysis of PGE2 and PGF2, was performed in duplicate directly on the incubation media by RIA. Briefly, tracer and antisera were added to standards and samples. After incubation overnight at 4" C, 0.5% charcoal and 0.05% dextran in buffer were added for 10 min to remove unbound PG. Samples were centrifuged for 5 min at 2000 x g and the supernatants counted with an LKB P counter. The antisera and PG standards were obtained from Sigma, and 3H-PGE2 (5.9 TBq/mmol) and 3H-PGFz,, (6.7 TBq/mmol) from Amersham International (Bucks, England). All other reagents were from British Drug Houses (Dorset, England).
Sensitivity of each assay was 5-200 pg/100 pl medium. Recovery of added PGs from the incubation media was 10 1 f 18% for PGE2 (n = 23) and 101 + 14% for PGF2, (n = 21), mean + SD. Because error is nonhomogenously distributed over a RIA standard curve (20) , precision was assessed at 5-20, 20-100, 100-200 pg/100 p1. The within-assay coefficient of variation for PGE2 was 8.5, 8.7, and 1 1.5 % and, for PGF,,, 19.6, 9.2, and 7.1 %. The between-assay coefficient of variation for PGE2 was 12.7, 9.2, and 14.9% and for PGF,,, 17.6, 9.3, and 13.9%. Specificity was assessed by sample dilution and by cross-reactivity. Dilution of sample closely followed the standard curve (r = 1 .O, gradient = 1.0 for PGE2 and r = 1.0, gradient = 0.97 for PGF2,; n = 2 1). Cross-reactivities of the antisera were confirmed for PGE2, PGF,,, 6KF1,, PGA2, PGB,, 13,14 dihydro-15-keto-PGF2,, arachidonic acid, and linoleic acid. Notable cross-reactivities were noted for PGF2,, 100% with PGFI, PGE,, and 3.2% with PGEI. All RIA calculations were performed by the logit probit analysis (2 1).
Subjects gave informed consent and the studies were approved by the hospital ethical and obstetric committees. The results are expressed as means + SEM and analysed by unpaired, bitailed Student's t test, and least squares linear regression analysis. Table 1) . Group I mothers and controls had similar leucocyte zinc levels. Group I1 mothers had significantly lower PMN and MN cell zinc concentrations. PMN and MN zinc levels were weakly correlated (r = 0.4, p < 0.05). There were no differences in the zinc contents of PMN or MN cells between smoking (n = 6) and nonsmoking (n = 18) controls and mothers: There were no significant differences in the mean PGE2 and F2, production by MC cells of control women and all mothers or by MC cells of mothers of AGA and SGA babies. However, all mothers had a higher E2/F2, ratio than nonpregnant controls and group I1 had a higher PGE2/PGF2, ratio than group I mothers ( Table 2) . Both results were chiefly due to lower PGF2, production by cells from group I1 mothers.
RESULTS

Zinc analysis (
There were weak correlations between zinc status and PGF2, production (r = 0.6, p < 0.05) and PGE2/PGF2, ratio (r = -0.7, p < 0.01) in pregnancy, n = 15 ( Fig. 1 ).
Mothers and controls were combined and the effect of smoking on PG production was analyzed. There was a tendency for monocytes from nonsmokers to produce more PGs than those from smokers, but the differences were not significant (162 +-23, n = 19 versus 96 + 26, n = 7 pg PGE2/105 MC/2 h and 175 + 30, n = 19 versus 100 + 32, n = 7 pg PGF2,/105 MC/2 h, nonsmokers versus smokers).
DISCUSSION
PMN cell zinc content is a simple and reliable indicator of tissue zinc status and its measurement requires less blood and is more reproducible than MN cell zinc. Maternal zinc depletion is associated with IUGR and this is confirmed in our recent larger study of 80 mothers, in which zinc depletion was also associated with smoking (22) . In addition to tissue zinc depletion, decreased umbilical arterial production of prostacyclin, measured as its stable product, 6-keto F,,, is also associated with IUGR (23) and smoking (24) , while umbilical prostacyclin production parallels umbilical blood flow (25) . Variations of umbilical blood flow might be an important factor controlling fetal size.
The measurement by RIA of PG production in vitro has advantages over using the radiolabeled precursor, arachidonic acid, for exogenous arachidonic acid is used by cells differently from the endogenous molecule (1 2), and it may not follow the endogenous substrate present or equilibrate with the same pool as that used for PG synthesis. Measuring the extra PG synthesized in response to a specific stimulus overcomes the problem of PGs being released by nonspecific stimuli during the preparation of cells.
Monocytes were the major leucocytes producing PGs, confirming previous work (26) . Significant differences in the absolute leucocyte PG production were not detected between controls and mothers of AGA and SGA babies, despite the latter group being zinc depleted and there being a weak correlation between PG production and PMN zinc status. However, group I1 mothers did have an increased PGE2/PGF2, ratio, mainly due to a trend to lower PGF2, production, indicating that PG production may be abnormal in mothers of SGA babies, possibly causing reduced placental perfusion.
Published results from studies with rats are conflicting. Zinc deficiency increased synthesis of PG by the placenta but not by the uterus (27) or kidney (28) . Mydani and Dupont (29) found that in most organs studied and for most PGs measured, food restriction was as efficient as zinc deficiency in reducing PG. However, zinc deficiency increased the level of 13, ICdihydro-15-keto PGF, in serum and reduced the concentration of PGE, PGF,, and 6 keto PGF, in gut contents (where PGE, and zinc were correlated). Kramer et al. (9) demonstrated that the phospholipids in the liver of both zinc-deficient and pair-fed control rats were similar, with increased products of A6 and A9 desaturase and decreased products of As and A4 desaturase. In laboratory rats the influence of reduced food intake, which accompanies zinc depletion, on the metabolism of linoleic acid to arachidonic acid may, therefore, be at least equal to that of zinc deficiency, and so without pair-fed controls the interpretation of results showing alteration in PG metabolism in zinc deficiency may have to be revised.
At present, therefore, we conclude that maternal zinc depletion, which is mild compared with severe experimental zinc deficiency, is not significantly sufficient to alter absolute PG production, but is associated with altered differential production of PGs by human leucocytes. More work, however, is needed to determine whether zinc status or malnutrition is related to placental and umbilical PG production, and thus to IUGR.
